BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol. 2000;42:549-566. [PMID: 10727299 DOI: 10.1067/mjd.2000.103909] [Cited by in Crossref: 188] [Cited by in F6Publishing: 93] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Karadağ Köse Ö, Güleç A. Temporal triangular alopecia: significance of trichoscopy in differential diagnosis. J Eur Acad Dermatol Venereol 2015;29:1621-5. [DOI: 10.1111/jdv.12656] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
2 Barcellos LF, Kamdar BB, Ramsay PP, Deloa C, Lincoln RR, Caillier S, Schmidt S, Haines JL, Pericak-vance MA, Oksenberg JR, Hauser SL. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. The Lancet Neurology 2006;5:924-31. [DOI: 10.1016/s1474-4422(06)70552-x] [Cited by in Crossref: 139] [Cited by in F6Publishing: 47] [Article Influence: 9.3] [Reference Citation Analysis]
3 Lie C, Liew CF, Oon HH. Alopecia and the metabolic syndrome. Clin Dermatol 2018;36:54-61. [PMID: 29241753 DOI: 10.1016/j.clindermatol.2017.09.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
4 Wasserman D, Guzman-Sanchez DA, Scott K, McMichael A. Alopecia areata. Int J Dermatol. 2007;46:121-131. [PMID: 17269961 DOI: 10.1111/j.1365-4632.2007.03193.x] [Cited by in Crossref: 131] [Cited by in F6Publishing: 85] [Article Influence: 9.4] [Reference Citation Analysis]
5 Martinez-Mir A, Zlotogorski A, Ott J, Gordon D, Christiano AM. Genetic linkage studies in alopecia areata. J Investig Dermatol Symp Proc 2003;8:199-203. [PMID: 14582673 DOI: 10.1046/j.1087-0024.2003.00809.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
6 Gautam RK, Singh Y, Gupta A, Arora P, Khurana A, Chitkara A. The profile of cytokines (IL‐2, IFN‐γ, IL‐4, IL‐10, IL‐17A, and IL‐23) in active alopecia areata. J Cosmet Dermatol 2020;19:234-40. [DOI: 10.1111/jocd.12970] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
7 Herz-ruelas ME, Welsh O, Gomez-flores M, Welsh E, Miranda-maldonado I, Ocampo-candiani J. Ultraviolet A-1 phototherapy as an alternative for resistant alopecia areata. Int J Dermatol 2015;54:e445-7. [DOI: 10.1111/ijd.13054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
8 Kavak A, Yeşildal N, Parlak AH, Gökdemir G, Aydoğan I, Anul H, Baykal C. Alopecia areata in Turkey: demographic and clinical features. J Eur Acad Dermatol Venereol 2008;22:977-81. [PMID: 18384559 DOI: 10.1111/j.1468-3083.2008.02699.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
9 Rossi A, Muscianese M, Piraccini BM, Starace M, Carlesimo M, Mandel VD, Alessandrini A, Calvieri S, Caro G, D'arino A, Federico A, Magri F, Pigliacelli F, Amendolagine G, Annunziata MC, Arisi MC, Astorino S, Babino G, Bardazzi F, Barruscotti S, Belloni Fortina A, Borghi A, Bruni F, Caccavale S, Calzavara-Pinton P, Cameli N, Cardone M, Carugno A, Coppola R, Dattola A, De Felici Del Giudice MB, Di Cesare A, Dika E, Di Nunno D, D'ovidio R, Fabbrocini G, Feliciani C, Fulgione E, Galluzzo M, Garcovich S, Garelli V, Guerriero C, Hansel K, La Placa M, Lacarrubba F, Lora V, Marinello E, Megna M, Micali G, Misciali C, Monari P, Monfrecola G, Neri I, Offidani A, Orlando G, Papini M, Patrizi A, Piaserico S, Rivetti N, Simonetti O, Stan TR, Stingeni L, Talamonti M, Tassone F, Villa L, Vincenzi C, Fortuna MC. Italian Guidelines in diagnosis and treatment of alopecia areata. G Ital Dermatol Venereol 2019;154:609-23. [PMID: 31578836 DOI: 10.23736/S0392-0488.19.06458-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
10 Kurosawa M, Nakagawa S, Mizuashi M, Sasaki Y, Kawamura M, Saito M, Aiba S. A Comparison of the Efficacy, Relapse Rate and Side Effects among Three Modalities of Systemic Corticosteroid Therapy for Alopecia Areata. Dermatology 2006;212:361-5. [DOI: 10.1159/000092287] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
11 Phan K, Lee G, Fischer G. Methotrexate in the treatment of paediatric alopecia areata: Retrospective case series and updated meta‐analysis. Australas J Dermatol 2020;61:119-24. [DOI: 10.1111/ajd.13206] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Kavak A, Yesildal N, Parlak AH. Effect of Two Consecutive Earthquakes on Outbreaks of Alopecia Areata. The Journal of Dermatology 2002;29:414-8. [DOI: 10.1111/j.1346-8138.2002.tb00296.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
13 Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, Shapiro J. Alopecia areata. Journal of the American Academy of Dermatology 2018;78:1-12. [DOI: 10.1016/j.jaad.2017.04.1141] [Cited by in Crossref: 108] [Cited by in F6Publishing: 74] [Article Influence: 36.0] [Reference Citation Analysis]
14 Bakry OA, Elshazly RM, Shoeib MA, Gooda A. Oxidative stress in alopecia areata: a case-control study. Am J Clin Dermatol 2014;15:57-64. [PMID: 23839259 DOI: 10.1007/s40257-013-0036-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
15 Waśkiel‐burnat A, Rakowska A, Sikora M, Olszewska M, Rudnicka L. Alopecia areata predictive score: A new trichoscopy‐based tool to predict treatment outcome in patients with patchy alopecia areata. J Cosmet Dermatol 2019;19:746-51. [DOI: 10.1111/jocd.13064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Rasheed Z, Alzolibani AA, Al-Shobaili HA, Saif GB, Al Robaee AA. Biochemical and immunological studies on erythrocytes superoxide dismutase modified by nitric oxide in patients with alopecia areata: Implications in alopecia patchy persistent and alopecia universalis. Immunol Lett 2014;160:50-7. [PMID: 24694751 DOI: 10.1016/j.imlet.2014.03.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
17 Delamere FM, Sladden MM, Dobbins HM, Leonardi-Bee J. Interventions for alopecia areata. Cochrane Database Syst Rev 2008;:CD004413. [PMID: 18425901 DOI: 10.1002/14651858.CD004413.pub2] [Cited by in Crossref: 58] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
18 Sohn K, Jang S, Choi D, Lee Y, Yoon T, Jeon EK, Kim KH, Seo Y, Lee J, Park J, Kim CD. Effect of thioredoxin reductase 1 on glucocorticoid receptor activity in human outer root sheath cells. Biochemical and Biophysical Research Communications 2007;356:810-5. [DOI: 10.1016/j.bbrc.2007.03.065] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
19 Islam N, Leung PS, Huntley AC, Eric Gershwin M. The autoimmune basis of alopecia areata: A comprehensive review. Autoimmunity Reviews 2015;14:81-9. [DOI: 10.1016/j.autrev.2014.10.014] [Cited by in Crossref: 82] [Cited by in F6Publishing: 67] [Article Influence: 13.7] [Reference Citation Analysis]
20 Bilgili SG, Ozkol H, Karadag AS, Ozkol HU, Seker A, Calka O, Aslan M. Serum paraoxonase activity and oxidative status in subjects with alopecia areata. Cutan Ocul Toxicol 2013;32:290-3. [PMID: 23590718 DOI: 10.3109/15569527.2013.781616] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
21 Suchonwanit P, Kositkuljorn C, Mahasaksiri T, Leerunyakul K. A comparison of the efficacy and tolerability of three corticosteroid treatment regimens in patients with alopecia areata. Journal of Dermatological Treatment. [DOI: 10.1080/09546634.2020.1773384] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
22 Choe SJ, Lee W. Efficacy of superficial cryotherapy on the eyebrows of patients with alopecia universalis also treated with contact immunotherapy on the scalp: a prospective, split-face comparative study. Int J Dermatol 2017;56:184-9. [DOI: 10.1111/ijd.13533] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Ucak H, Cicek D, Demir B, Erden I, Ozturk S. Prognostic factors that affect the response to topical treatment in patchy alopecia areata: The response to topical treatment in patchy alopecia areata. Journal of the European Academy of Dermatology and Venereology 2014;28:34-40. [DOI: 10.1111/jdv.12043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
24 Haines ML, Anderson RP, Gibson PR. Systematic review: The evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther. 2008;28:1042-1066. [PMID: 18671779 DOI: 10.1111/j.1365-2036.2008.03820.x] [Cited by in Crossref: 124] [Cited by in F6Publishing: 109] [Article Influence: 9.5] [Reference Citation Analysis]
25 Malgouries S, Thibaut S, Bernard BA. Proteoglycan expression patterns in human hair follicle. Br J Dermatol 2008;158:234-42. [PMID: 18067481 DOI: 10.1111/j.1365-2133.2007.08339.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
26 Kim BJ, Uk min S, Park KY, Choi JW, Park SW, Youn SW, Park KC, Huh CH. Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata. Journal of Dermatological Treatment 2009;19:216-20. [DOI: 10.1080/09546630701846095] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
27 Dall'oglio F, Nasca MR, Musumeci ML, La Torre G, Ricciardi G, Potenza C, Micali G. Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): Results of an open‐label, paired‐comparison, clinical trial. Journal of Dermatological Treatment 2009;16:10-4. [DOI: 10.1080/09546630410023601] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
28 Wu M, Yang C, Tsai R, Chen W. Late-onset alopecia areata: A retrospective study of 73 patients from Taiwan: Late-onset alopecia areata. Journal of the European Academy of Dermatology and Venereology 2013;27:468-72. [DOI: 10.1111/j.1468-3083.2012.04467.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
29 Koc E, Tunca M, Akar A, Kurumlu Z. Lack of efficacy of topical imiquimod in the treatment of patchy alopecia areata. International Journal of Dermatology 2008;47:1088-9. [DOI: 10.1111/j.1365-4632.2008.03327.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
30 Uchiyama M, Egusa C, Hobo A, Irisawa R, Yamazaki M, Tsuboi R. Multivariate analysis of prognostic factors in patients with rapidly progressive alopecia areata. Journal of the American Academy of Dermatology 2012;67:1163-73. [DOI: 10.1016/j.jaad.2012.06.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
31 Erfan G, Albayrak Y, Yanik ME, Oksuz O, Tasolar K, Topcu B, Unsal C. Distinct temperament and character profiles in first onset vitiligo but not in alopecia areata. J Dermatol 2014;41:709-15. [PMID: 25099156 DOI: 10.1111/1346-8138.12553] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
32 Han Y, Sheng Y, Xu F, Qi S, Liu X, Hu R, Miao Y, Huang G, Yang Q. Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata. J Dermatol 2015;42:981-8. [DOI: 10.1111/1346-8138.12978] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
33 Waśkiel‐burnat A, Kołodziejak M, Sikora M, Stochmal A, Rakowska A, Olszewska M, Rudnicka L. Therapeutic management in paediatric alopecia areata: A systematic review. J Eur Acad Dermatol Venereol 2021;35:1299-308. [DOI: 10.1111/jdv.17187] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Sharquie KE, Al-Obaidi HK. Onion juice (Allium cepa L.), a new topical treatment for alopecia areata. J Dermatol 2002;29:343-6. [PMID: 12126069 DOI: 10.1111/j.1346-8138.2002.tb00277.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
35 Weedon D. Diseases of cutaneous appendages. Weedon's Skin Pathology. Elsevier; 2010. pp. 397-440.e34. [DOI: 10.1016/b978-0-7020-3485-5.00016-4] [Cited by in Crossref: 10] [Article Influence: 0.9] [Reference Citation Analysis]
36 Bilgic O, Sivrikaya A, Unlu A, Altinyazar HC. Serum cytokine and chemokine profiles in patients with alopecia areata. Journal of Dermatological Treatment 2015;27:260-3. [DOI: 10.3109/09546634.2015.1093591] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
37 Kamel MM, Salem SAM, Attia HHM. Successful treatment of resistant alopecia areata with a phototoxic dose of ultraviolet A after topical 8-methoxypsoralen application: Phototoxic PUVA in resistant alopecia areata. Photodermatology, Photoimmunology & Photomedicine 2011;27:45-50. [DOI: 10.1111/j.1600-0781.2010.00564.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
38 Lee YH, Choi HJ, Kim JY, Kim JE, Lee JH, Cho SH, Yun MY, An S, Song GY, Bae S. Ginsenoside Rg4 Enhances the Inductive Effects of Human Dermal Papilla Spheres on Hair Growth Via the AKT/GSK-3β/β-Catenin Signaling Pathway. J Microbiol Biotechnol 2021;31:933-41. [PMID: 34099599 DOI: 10.4014/jmb.2101.01032] [Reference Citation Analysis]
39 Strazzulla LC, Avila L, Lo Sicco K, Shapiro J. Image Gallery: Treatment of refractory alopecia universalis with oral tofacitinib citrate and adjunct intralesional triamcinolone injections. Br J Dermatol 2017;176:e125. [PMID: 28581223 DOI: 10.1111/bjd.15483] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
40 Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol. 2003;121:985-988. [PMID: 14708596 DOI: 10.1046/j.1523-1747.2003.12540.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 56] [Article Influence: 5.5] [Reference Citation Analysis]
41 Barankin B, Taher M, Wasel N. Successful hair transplant of eyebrow alopecia areata. J Cutan Med Surg 2005;9:162-4. [PMID: 16502201 DOI: 10.1007/s10227-005-0136-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
42 Miteva M, Tosti A. Treatment options for alopecia: an update, looking to the future. Expert Opin Pharmacother. 2012;13:1271-1281. [PMID: 22594679 DOI: 10.1517/14656566.2012.685160] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
43 Lacarrubba F, Dall???oglio F, Rita Nasca M, Micali G. Videodermatoscopy Enhances Diagnostic Capability in Some Forms of Hair Loss: . American Journal of Clinical Dermatology 2004;5:205-8. [DOI: 10.2165/00128071-200405030-00009] [Cited by in Crossref: 65] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
44 Loh SH, Moon HN, Lew BL, Sim WY. Role of T helper 17 cells and T regulatory cells in alopecia areata: comparison of lesion and serum cytokine between controls and patients. J Eur Acad Dermatol Venereol 2018;32:1028-33. [PMID: 29283462 DOI: 10.1111/jdv.14775] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
45 Al-mutairi N. 308-nm Excimer Laser for the Treatment of Alopecia Areata in Children. Pediatric Dermatology 2009;26:547-50. [DOI: 10.1111/j.1525-1470.2009.00980.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
46 Tricot L, Lebbé C, Pillebout E, Martinez F, Legendre C, Thervet E. Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients. Transplantation. 2005;80:1546-1549. [PMID: 16371923 DOI: 10.1097/01.tp.0000181195.67084.94] [Cited by in Crossref: 45] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
47 Harrison S, Sinclair R. Optimal Management of Hair Loss (Alopecia) in Children: . American Journal of Clinical Dermatology 2003;4:757-70. [DOI: 10.2165/00128071-200304110-00004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
48 Açıkgöz G, Çalışkan E, Tunca M, Yeniay Y, Akar A. The effect of oral cyclosporine in the treatment of severe alopecia areata. Cutaneous and Ocular Toxicology 2013;33:247-52. [DOI: 10.3109/15569527.2013.839997] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
49 Priego-Recio CM, Rodríguez-Pichardo A, Camacho-Martínez FM. Unusual forms of alopecia areata in a Trichology Unit. J Eur Acad Dermatol Venereol 2014;28:1394-6. [PMID: 24033384 DOI: 10.1111/jdv.12250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
50 Galán-gutiérrez M, Rodríguez-bujaldón A, Moreno-giménez J. Update on the Treatment of Alopecia Areata. Actas Dermo-Sifiliográficas (English Edition) 2009;100:266-76. [DOI: 10.1016/s1578-2190(09)70063-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
51 Alatas FS, Matsuura T, Yoshimaru K, Kadim M, Taguchi T. Alopecia in Children Following Living Related Liver Transplantation. Transplant Proc 2021;53:228-32. [PMID: 32605770 DOI: 10.1016/j.transproceed.2020.05.020] [Reference Citation Analysis]
52 Henn W, Zlotogorski A, Lam H, Martinez-Mir A, Zaun H, Christiano AM. Atrichia with papular lesions resulting from compound heterozygous mutations in the hairless gene: A lesson for differential diagnosis of alopecia universalis. J Am Acad Dermatol 2002;47:519-23. [PMID: 12271294 DOI: 10.1067/mjd.2002.124609] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
53 Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, Shapiro J. Alopecia areata. Journal of the American Academy of Dermatology 2018;78:15-24. [DOI: 10.1016/j.jaad.2017.04.1142] [Cited by in Crossref: 78] [Cited by in F6Publishing: 53] [Article Influence: 26.0] [Reference Citation Analysis]
54 Tosti A, Piraccini BM, Pazzaglia M, Vincenzi C. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. J Am Acad Dermatol 2003;49:96-8. [PMID: 12833016 DOI: 10.1067/mjd.2003.423] [Cited by in Crossref: 99] [Cited by in F6Publishing: 52] [Article Influence: 5.5] [Reference Citation Analysis]
55 Almohanna HM, Ahmed AA, Griggs JW, Tosti A. Platelet-Rich Plasma in the Treatment of Alopecia Areata: A Review. J Investig Dermatol Symp Proc. 2020;20:S45-S49. [PMID: 33099384 DOI: 10.1016/j.jisp.2020.05.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
56 Hunter N, Shaker O, Marei N. Diphencyprone and topical tacrolimus as two topical immunotherapeutic modalities. Are they effective in the treatment of alopecia areata among Egyptian patients? A study using CD4, CD8 and MHC II as markers. J Dermatolog Treat 2011;22:2-10. [PMID: 20524872 DOI: 10.3109/09546630903410182] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
57 Barankin B, Taher M, Wasel N. Successful Hair Transplant of Eyebrow Alopecia Areata. J Cutan Med Surg 2005;9:162-4. [DOI: 10.1177/120347540500900402] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
58 Amin SS, Sachdeva S. Alopecia areata: A review. Journal of the Saudi Society of Dermatology & Dermatologic Surgery 2013;17:37-45. [DOI: 10.1016/j.jssdds.2013.05.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
59 Rivitti EA. Alopecia areata: revisão e atualização. An Bras Dermatol 2005;80:57-68. [DOI: 10.1590/s0365-05962005000100009] [Cited by in Crossref: 16] [Article Influence: 1.0] [Reference Citation Analysis]
60 Poulos GA, Mirmirani P. Investigational medications in the treatment of alopecia. Expert Opin Investig Drugs 2005;14:177-84. [PMID: 15757393 DOI: 10.1517/13543784.14.2.177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
61 Coda AB, Qafalijaj Hysa V, Seiffert-Sinha K, Sinha AA. Peripheral blood gene expression in alopecia areata reveals molecular pathways distinguishing heritability, disease and severity. Genes Immun 2010;11:531-41. [PMID: 20535136 DOI: 10.1038/gene.2010.32] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
62 Pandhi D, Singal A, Gupta R, Das G. Ocular alterations in patients of alopecia areata. The Journal of Dermatology 2009;36:262-8. [DOI: 10.1111/j.1346-8138.2009.00636.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
63 Sellheyer K, Bergfeld WF. Histopathologic Evaluation of Alopecias: . The American Journal of Dermatopathology 2006;28:236-59. [DOI: 10.1097/00000372-200606000-00051] [Cited by in Crossref: 62] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
64 Al-mutairi N. 308-nm Excimer Laser for the Treatment of Alopecia Areata: . Dermatologic Surgery 2007;33:1483-7. [DOI: 10.1097/00042728-200712000-00011] [Cited by in Crossref: 52] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
65 Mulinari-brenner F. Psychosomatic aspects of alopecia areata. Clinics in Dermatology 2018;36:709-13. [DOI: 10.1016/j.clindermatol.2018.08.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
66 Chow S, Rizzo C, Ravitskiy L, Sinha AA. The role of T cells in cutaneous autoimmune disease. Autoimmunity 2009;38:303-17. [DOI: 10.1080/08916930500124429] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
67 Suárez-Fariñas M, Ungar B, Noda S, Shroff A, Mansouri Y, Fuentes-Duculan J, Czernik A, Zheng X, Estrada YD, Xu H, Peng X, Shemer A, Krueger JG, Lebwohl MG, Guttman-Yassky E. Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing. J Allergy Clin Immunol 2015;136:1277-87. [PMID: 26316095 DOI: 10.1016/j.jaci.2015.06.032] [Cited by in Crossref: 107] [Cited by in F6Publishing: 90] [Article Influence: 17.8] [Reference Citation Analysis]
68 Tosti A, Duque-estrada B. Treatment strategies for alopecia. Expert Opinion on Pharmacotherapy 2009;10:1017-26. [DOI: 10.1517/14656560902876368] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
69 Phan K, Ramachandran V, Sebaratnam DF. Methotrexate for alopecia areata: A systematic review and meta-analysis. Journal of the American Academy of Dermatology 2019;80:120-127.e2. [DOI: 10.1016/j.jaad.2018.06.064] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
70 Lyakhovitsky A, Shemer A, Amichai B. Increased prevalence of thyroid disorders in patients with new onset alopecia areata. Australas J Dermatol 2015;56:103-6. [PMID: 25303421 DOI: 10.1111/ajd.12178] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
71 Bernárdez C, Molina-Ruiz AM, Requena L. Histologic features of alopecias-part I: nonscarring alopecias. Actas Dermosifiliogr 2015;106:158-67. [PMID: 25444580 DOI: 10.1016/j.ad.2014.07.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
72 Herz-ruelas ME, Gomez-flores M, Miranda-maldonado I, Welsh E, Ocampo-candiani J, Welsh O. Escalating dosimetry of UVA-1 in the treatment of alopecia areata. Int J Dermatol 2017;56:653-9. [DOI: 10.1111/ijd.13572] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
73 Tan E, Tay YK, Goh CL, Chin Giam Y. The pattern and profile of alopecia areata in Singapore--a study of 219 Asians. Int J Dermatol. 2002;41:748-753. [PMID: 12452996 DOI: 10.1046/j.1365-4362.2002.01357.x] [Cited by in Crossref: 130] [Cited by in F6Publishing: 96] [Article Influence: 7.2] [Reference Citation Analysis]
74 Renert-yuval Y, Guttman-yassky E. A novel therapeutic paradigm for patients with extensive alopecia areata. Expert Opinion on Biological Therapy 2016;16:1005-14. [DOI: 10.1080/14712598.2016.1188076] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
75 Chartaux E, Joly P. [Long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalis]. Ann Dermatol Venereol 2010;137:507-13. [PMID: 20804893 DOI: 10.1016/j.annder.2010.06.031] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
76 Semalty M, Semalty A, Joshi GP, Rawat MS. Hair growth and rejuvenation: an overview. J Dermatolog Treat 2011;22:123-32. [PMID: 20536276 DOI: 10.3109/09546630903578574] [Cited by in Crossref: 52] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
77 Subramanya RD, Coda AB, Sinha AA. Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures. Genomics 2010;96:146-53. [PMID: 20546884 DOI: 10.1016/j.ygeno.2010.05.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
78 Ucak H, Kandi B, Cicek D, Halisdemir N, Dertlıoğlu SB. The comparison of treatment with clobetasol propionate 0.05% and topical pimecrolimus 1% treatment in the treatment of alopecia areata. J Dermatolog Treat 2012;23:410-20. [PMID: 21787210 DOI: 10.3109/09546634.2011.590788] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
79 Randall VA. Is alopecia areata an autoimmune disease? The Lancet 2001;358:1922-4. [DOI: 10.1016/s0140-6736(01)06943-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
80 Yenin JZ, Serarslan G, Yönden Z, Ulutaş KT. Investigation of oxidative stress in patients with alopecia areata and its relationship with disease severity, duration, recurrence and pattern. Clin Exp Dermatol 2015;40:617-21. [PMID: 25524272 DOI: 10.1111/ced.12556] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
81 Francomano M, Seidenari S. Urticaria after topical immunotherapy with diphenylcyclopropenone: CONTACT POINT. Contact Dermatitis 2002;47:310-1. [DOI: 10.1034/j.1600-0536.2002.4705102.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
82 Alkhalifah A. Alopecia Areata Update. Dermatologic Clinics 2013;31:93-108. [DOI: 10.1016/j.det.2012.08.010] [Cited by in Crossref: 46] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
83 Ohtsuki A, Hasegawa T, Ikeda S. Treatment of alopecia areata with 308-nm excimer lamp: 308-nm excimer lamp for alopecia areata. The Journal of Dermatology 2010;37:1032-5. [DOI: 10.1111/j.1346-8138.2010.00942.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
84 Cranwell WC, Lai VW, Photiou L, Meah N, Wall D, Rathnayake D, Joseph S, Chitreddy V, Gunatheesan S, Sindhu K, Sharma P, Green J, Eisman S, Yip L, Jones L, Sinclair R. Treatment of alopecia areata: An Australian expert consensus statement. Australas J Dermatol 2019;60:163-70. [DOI: 10.1111/ajd.12941] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
85 Esmer O, Karadag R, Cakici O, Bilgili SG, Demircan YT, Bayramlar H, Karadag AS. Ocular findings in patients with alopecia areata. Int J Dermatol 2016;55:814-8. [DOI: 10.1111/ijd.13114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
86 Sprecher E, Lestringant GG, Szargel R, Bergman R, Labay V, Frossard PM, Friedman-birnbaum R, Cohen N. Reply. Journal of Investigative Dermatology 2000;115:762-3. [DOI: 10.1046/j.1523-1747.2000.00124-2.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
87 Gundogan C, Greve B, Raulin C. Treatment of alopecia areata with the 308-nm xenon chloride excimer laser: Case report of two successful treatments with the excimer laser. Lasers Surg Med 2004;34:86-90. [DOI: 10.1002/lsm.20002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
88 Farshi S, Mansouri P, Safar F, Khiabanloo SR. Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study: Azathioprine for alopecia areata. International Journal of Dermatology 2010;49:1188-93. [DOI: 10.1111/j.1365-4632.2010.04576.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
89 Cetin ED, Şavk E, Uslu M, Eskin M, Karul A. Investigation of the Inflammatory Mechanisms in Alopecia Areata. The American Journal of Dermatopathology 2009;31:53-60. [DOI: 10.1097/dad.0b013e318185a66e] [Cited by in Crossref: 38] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
90 Galán-gutiérrez M, Rodríguez-bujaldón A, Moreno-giménez J. Actualización terapéutica en alopecia areata. Actas Dermo-Sifiliográficas 2009;100:266-76. [DOI: 10.1016/s0001-7310(09)70820-8] [Cited by in Crossref: 10] [Article Influence: 0.8] [Reference Citation Analysis]
91 Saltik-temizel IN, Ersoy-evans S, Demir H, Yüce A. Pityriasis Lichenoides Chronica: An Association with Autoimmune Hepatitis?: Pityriasis Lichenoides Chronica. Pediatric Dermatology 2007;24:71-3. [DOI: 10.1111/j.1525-1470.2007.00339.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
92 Duvic M, Norris D, Christiano A, Hordinsky M, Price V. Alopecia Areata Registry: An Overview. Journal of Investigative Dermatology Symposium Proceedings 2003;8:219-21. [DOI: 10.1046/j.1087-0024.2003.00814.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
93 Putterman E, Patel DP, Andrade G, Harfmann KL, Hogeling M, Cheng CE, Goh C, Rogers RS, Castelo-soccio L. Severity of disease and quality of life in parents of children with alopecia areata, totalis, and universalis: A prospective, cross-sectional study. Journal of the American Academy of Dermatology 2019;80:1389-94. [DOI: 10.1016/j.jaad.2018.12.051] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]